Anrotinib test group:Antilotinib 12mg, once a day for 14 days, 7 days for 1 cycle, repeated every 21 days

2 trials

Sponsors

Guilin Traditional Chinese Medicine Hospital

Conditions

Hepatocellular carcinoma

Early Phase 1

Clinical study for the first-line treatment of advanced hepatocellular carcinoma with anrotinib hydrochloride capsule

Active, not recruitingITMCTR1900002329

Guilin Traditional Chinese Medicine HospitalHepatocellular carcinoma

Start: 2019-06-01Updated: 2023-02-20

Clinical study for the first-line treatment of advanced hepatocellular carcinoma with anrotinib hydrochloride capsule

Active, not recruitingChiCTR1900023088

Guilin Traditional Chinese Medicine HospitalHepatocellular carcinoma

Start: 2019-06-01Updated: 2019-05-13